ENTELLUS MED INC's ticker is ENTL and the CUSIP is 29363K105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $2,476,000 | -16.4% | 130,496 | -2.3% | 0.27% | -5.8% |
Q3 2016 | $2,963,000 | +11.1% | 133,596 | -8.5% | 0.29% | +5.8% |
Q2 2016 | $2,668,000 | -2.0% | 146,006 | -2.4% | 0.28% | +108.3% |
Q1 2016 | $2,722,000 | +20838.5% | 149,665 | +29536.6% | 0.13% | +13100.0% |
Q2 2015 | $13,000 | – | 505 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 2,956,456 | $48,960,000 | 52.70% |
Discovery Group I, LLC | 2,169,729 | $35,931,000 | 10.38% |
Essex Woodlands Management, Inc. | 3,231,656 | $53,516,000 | 9.68% |
Archon Capital Management LLC | 478,820 | $7,929,000 | 6.46% |
First Light Asset Management, LLC | 512,416 | $8,486,000 | 2.85% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 341,468 | $5,655,000 | 2.15% |
Ghost Tree Capital, LLC | 375,000 | $6,210,000 | 1.29% |
PERKINS CAPITAL MANAGEMENT INC | 68,316 | $1,131,000 | 1.25% |
Cypress Capital Management LLC (WY) | 63,540 | $1,052,222,000 | 1.21% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 35,000 | $580,000 | 0.66% |